EphA2 represents an important antigen that can be used for immunotherapy-based strategies, as EphA2 immunotherapy represents a promising frontier in cancer treatment, with ongoing research aimed at optimizing efficacy and safety. This evidence concerns the gene EPHA2 and cancer.